TherapeuticsMD, Inc. (TXMD) Q4 2021 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Therapeuticsmd, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.291 Good morning, ladies and gentlemen. Thank you for joining us for the Therapeutics MD 00:00:04.291 -- 00:00:08.033 fourth quarter 2021 financial results conference call. 00:00:08.033 -- 00:00:12.916 Following prepared remarks from the company, we will open the call for questions. 00:00:12.916 -- 00:00:16.798 I would now like to turn the call over to Investor Relations for Therapeutics MD, Lisa 00:00:16.798 -- 00:00:19.239 Wilson. Lisa? 00:00:19.239 -- 00:00:24.522 Thank you, Operator. Good morning, everyone, and thank you for joining us today to discuss 00:00:24.522 -- 00:00:28.715 our fourth quarter financial results and business updates. 00:00:28.715 -- 00:00:31.216 This morning, TherapeuticsMD 00:00:31.216 -- 00:00:35.576 issued a press release announcing its fourth quarter 21 00:00:35.576 -- 00:00:40.597 financial results. The press release and accompanying presentation are 00:00:40.597 -- 00:00:45.638 available on the company's website, therapeuticsmd.com, 00:00:45.779 -- 00:00:52.220 in the Investors and Media section. On today's call from TherapeuticsMD, 00:00:52.220 -- 00:00:58.519 our Chief Executive Officer, Hugh O'Dowd, Chief Financial Officer, James Durecka, 00:00:58.519 -- 00:01:02.561 and Chief Financial Commercial Officer Mark Glickman. 00:01:02.561 -- 00:01:08.184 I would like to remind everyone that certain statements made during this conference call 00:01:08.184 -- 00:01:13.487 may be forward-looking statements. Such forward-looking statements are based upon current 00:01:13.487 -- 00:01:14.907 expectations, 00:01:14.907 -- 00:01:19.710 and there can be no assurance that the results contemplated in these statements will 00:01:19.710 -- 00:01:21.791 be realized. 00:01:21.791 -- 00:01:27.034 Actual results may differ...